Andrew Lipsky

Genome-wide cell-free DNA mutational integration enables ultra-sensitive cancer monitoring

Asaf Zviran, Rafael Schulman, Minita Shah et al. · Nature Medicine · 2020 · 411 citations · Full text

Ultra-sensitive Cancer Monitoring, Medicine, Cancer Genomics +4

Ibrutinib for previously untreated and relapsed or refractory chronic lymphocytic leukaemia with TP53 aberrations: a phase 2, single-arm trial

Mohammed Farooqui, Janet Valdez, Sabrina Martyr et al. · The Lancet Oncology · 2014 · 365 citations · Full text

Hematological Malignancy, Lymphoid Neoplasia, Tp53 Aberrations +8

Partial reconstitution of humoral immunity and fewer infections in patients with chronic lymphocytic leukemia treated with ibrutinib

Clare Sun, Xin Tian, Yuh Shan Lee et al. · Blood · 2015 · 218 citations · Full text

Ibrutinib-induced lymphocytosis in patients with chronic lymphocytic leukemia: correlative analyses from a phase II study

Sarah E. M. Herman, Carsten Utoft Niemann, Mahfooz Farooqui et al. · Leukemia · 2014 · 187 citations · Full text

Hematological Malignancy, Lymphoid Neoplasia, Chronic Lymphocytic Leukemia +9

Incidence and risk factors of bleeding-related adverse events in patients with chronic lymphocytic leukemia treated with ibrutinib

Andrew Lipsky, Mohammed Z.H. Farooqui, Xin Tian et al. · Haematologica · 2015 · 165 citations · Full text